Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
65 studies found for:    human epidermal growth factor receptor type 2 (HER2)
Show Display Options
Rank Status Study
1 Not yet recruiting A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer
Condition: Breast Neoplasms
Intervention: Other: Local Therapy
2 Active, not recruiting Evaluation of Trastuzumab Without Chemotherapy as a Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: trastuzumab;   Drug: chemotherapy
3 Recruiting A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Patients With Metastatic Her 2- Negative and Aggressive Disease Criteria
Condition: Metastatic Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Paclitaxel
4 Completed A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors
Condition: Tumors
Intervention: Drug: CUDC-101
5 Completed
Has Results
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
Conditions: Head and Neck Cancer;   Liver Cancer;   Breast Cancer;   Gastric Cancer;   Non-Small Cell Lung Cancer
Intervention: Drug: CUDC-101
6 Completed Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: CUDC-101;   Drug: Cisplatin;   Radiation: Radiation Therapy
7 Completed Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity
Conditions: Left Ventricular Function Systolic Dysfunction;   Cardiotoxicity
Intervention:
8 Completed The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors
Condition: Solid Tumors
Intervention: Drug: Lapatinib and Sorafenib
9 Active, not recruiting
Has Results
Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cisplatin;   Drug: bevacizumab;   Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel
10 Completed Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
Condition: Neoplasms, Breast
Intervention: Drug: Lapatinib plus capecitabine
11 Recruiting Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour;   Breast Cancer;   Malignant Tumor of Colon;   GIST;   Ovarian Cancer
Interventions: Biological: HER-2 vaccine;   Biological: Extension HER-2 vaccine trial at OBD
12 Recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: PD0332991;   Drug: Anastrozole;   Drug: Goserelin;   Procedure: Surgery (standard of care);   Procedure: Tumor biopsy
13 Completed A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED)
Condition: Cancer
Interventions: Biological: V930;   Biological: V932
14 Active, not recruiting Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
Condition: HER-2 Positive Breast Cancer
Intervention: Drug: Pertuzumab, Trastuzumab and Eribulin
15 Completed
Has Results
Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma
Condition: Gastric Cancer, Gastroesophageal Junction Cancer
Intervention: Biological: Trastuzumab
16 Recruiting T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With Glioblastoma
Condition: Glioblastoma
Intervention: Genetic: HER2-specific T cells
17 Recruiting Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Condition: Sarcoma
Interventions: Genetic: Autologous HER2-specific T cells;   Drug: Fludarabine;   Drug: Cyclophosphamide
18 Unknown  Her 2 Testing in Indian Patients With Gastric Cancer
Condition: Gastric Cancer
Intervention:
19 Recruiting International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study
Condition: Breast Cancer
Interventions: Genetic: Germline BRCA Test (blood);   Genetic: FoundationOne Dx Genomic Profile (archival Tumour Specimen);   Other: Follow-up
20 Not yet recruiting Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
Conditions: Breast Cancer;   Breast Cancer, Male;   Breast Cancer Female;   HER2-positive Breast Cancer
Interventions: Biological: Interferon-gamma (IFN-γ);   Drug: Paclitaxel;   Drug: Trastuzumab;   Other: Pertuzumab;   Procedure: Post Therapy Surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.